Disappointing data prompts Pfizer to drop heart drug acquired as part of $11 billion deal – MedCity News
When Pfizer acquired Array Biopharma for $11.4 billion three years ago, the focus was FDA-approved cancer drugs. The buyout also came with drug candidates in development for other diseases, and…